HARRIGAN EDMUND 4

What Happened

• Director Edmund Harrigan reported exercising option(s) and receiving restricted stock units (RSUs) on May 29, 2026. The filing shows: exercise/conversion of 8,107 option-derived shares and grants/awards of 16,004 and 9,311 restricted stock units (totaling 33,422 shares/units). An equal number of 8,107 shares from the exercise were reported as disposed at $0 (derivative), while the RSUs and the exercise show $0 per-share in the filing (typical for award reporting).
• This activity is not an open-market purchase or sale for cash; it represents option exercise and issuance/vesting of stock units (acquisitions), with a portion of exercised shares surrendered/treated at $0 in the report (commonly used to satisfy withholding or exercise settlement obligations).

Key Details

• Transaction date: May 29, 2026; Form 4 filed June 1, 2026 (timely — within the two-business-day filing requirement).
• Reported transactions: exercised/conversion of 8,107 shares (code M); 8,107 shares also reported disposed at $0 (derivative). Grants/awards (code A) of 16,004 and 9,311 restricted stock units (RSUs).
• Prices/values reported: $0.00 per share for awards and the disposed portion; exercise acquired shares listed as N/A for price in filing.
• Shares owned after the transaction: not specified in the information provided in this Form 4.
• Footnotes: F1-F4 explain that RSUs represent contingent rights to receive one share each; some RSUs vested in full on May 29, 2026 (F2). Option and RSU vesting schedules are described (quarterly vesting over one year for options per F3; some RSUs vest earlier of one year or next annual meeting per F4).

Context

• For retail investors: this filing reflects insider equity compensation events (option exercise and RSU awards/vestings), not an open-market buy or sale for cash. The reported disposal of 8,107 shares at $0 likely reflects shares surrendered/used in settlement (e.g., tax withholding or exercise cost), a common administrative step that does not necessarily indicate a market sale.
• These types of filings are routine for directors receiving and settling equity-based compensation; they do not by themselves signal a change in the director’s view of the company.